•
Sep 30, 2012

Ironwood Pharmaceuticals Q3 2012 Earnings Report

Total Revenue
$96.4M
Previous year: $12.2M
+689.0%
EPS
$0.42
Previous year: -$0.21
-300.0%
Gross Profit
$70.5M
Previous year: $12.2M
+476.6%
Cash and Equivalents
$126M
Previous year: $68.8M
+82.9%
Free Cash Flow
$35.4M
Previous year: -$26M
-236.4%
Total Assets
$247M
Previous year: $219M
+12.3%

Ironwood Pharmaceuticals

Ironwood Pharmaceuticals